Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FE3P0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,066
Award facts
- Contract value 100% obligated
- $10,066.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $10,066.41 under a firm fixed price contract. This is a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and represents a child contract executed under a larger vehicle. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management and cardiovascular disease prevention, indicating this delivery supports federal medical supply requirements.
This delivery order is executed under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical vendor for federal military healthcare systems, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices through the DLA Medical Supply Chain to support Department of Defense healthcare programs worldwide. The company's extensive federal contracting history demonstrates consistent capability to meet competitive procurement standards for high-value pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DB25FE3P0?
SPE2DB25FE3P0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FE3P0 worth?
The government has obligated $10,066 on SPE2DB25FE3P0.
Is contract SPE2DB25FE3P0 an order under another contract?
Yes. SPE2DB25FE3P0 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3P0 competed?
The extent of competition for SPE2DB25FE3P0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award